IngentaConnect Balanced translocation in a patient with severe myoclonic epileps...

Authors: Møller, Rikke S.; Schneider, Lizette M.¹; Hansen, Christian P.²; Bugge, Merete¹; Ullmann, Reinhard³; Tommerup, Niels¹; Tümer, Zeynep¹

Source: Epilepsia, Volume 49, Number 6, June 2008 , pp. 1091-1094(4)

Publisher: Blackwell Publishing

Abstract:

Summary

In a patient with severe myoclonic epilepsy of infancy (SMEI), we identified a de novo balanced translocation, t(2;5)(q24.3,q34). The breakpoint on chromosome 2q24.3 truncated the SCN1A gene and the 5q34 breakpoint was within a highly conserved genomic region. Point mutations or microdeletions of SCN1A have previously been identified in SMEI patients, but this is the first report of a balanced translocation disrupting the SCN1A gene in an epilepsy patient. We therefore recommend that SMEI patients without SCN1A microdeletions or point mutations should be investigated for chromosomal rearrangements.

Keywords: Epilepsy; SCN1A; Balanced translocation; Mental retardation; SMEI

Document Type: Research article

DOI: 10.1111/j.1528-1167.2008.01550.x

Affiliations: 1: Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark 2: Danish Epilepsy Centre, Dianalund, Denmark 3: Max-Planck Institute for Molecular Genetics, Berlin, Germany

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Balanced translocation in a patient with severe myoclonic epilepsy of infancy disrupts the sodium channel gene SCN1A